Department of Dermatology
Dermatology | Health Services Administration | Infectious Disease | Skin and Connective Tissue Diseases | Telemedicine | Virus Diseases
To the editor: 34 Longitudinal melanonychia (LM) is the presenting sign of nail unit melanoma (NUM) in 2/3 35 of cases and is therefore among the most important conditions managed by dermatologists. In 36 normal times, referral for LM would prompt an expedited appointment for clinical 37 examination and dermoscopy.1 However, due to SARS-CoV-2, dermatologists have been 38 asked to reconsider “urgent/emergency” conditions. The COVID-19 pandemic has propelled 39 physicians to unexpectedly adopt telemedicine without adequate guidance for managing LM 40 patients.
COVID-19, SARS-CoV-2, coronavirus, dermoscopy, en bloc excision, hemostasis, longitudinal melanonychia, melanocytic activation, nail biopsy, nail matrix nevus, nail unit melanoma, onychoscopy, pandemic, subungual melanoma, telemedicine
Rights and Permissions
© 2020 by the American Academy of Dermatology. This is a PDF file of an accepted manuscript that has been accepted for publication and posted with a 12-month embargo and CC BY-NC-ND license as allowed by the publisher's author rights policy at https://www.elsevier.com/about/policies/sharing.
DOI of Published Version
Lipner SR, Iorizzo M, Jellinek N, Piraccini BM, Scher RK. Considerations for Management of Longitudinal Melanonychia During the COVID-19 Pandemic: An International Perspective. J Am Acad Dermatol. 2020 May 13. doi: 10.1016/j.jaad.2020.05.028. Epub ahead of print. PMID: 32405124; PMCID: PMC7217794. Link to article on publisher's site
Journal of the American Academy of Dermatology
Lipner SR, Iorizzo M, Jellinek N, Piraccini BM, Scher RK. (2020). Considerations for Management of Longitudinal Melanonychia During the COVID-19 Pandemic: An International Perspective. COVID-19 Publications by UMMS Authors. https://doi.org/10.1016/j.jaad.2020.05.028. Retrieved from https://escholarship.umassmed.edu/covid19/32
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.